Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Phase II NCT06014138

Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome

Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome — Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06014138.

📅 04 Jun 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Phase II
NCT ID
NCT06014138
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Start
2023-11-01
ClinicaliQ Trial Snapshot
  • Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome — Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06014138.
  • What is being tested: The trial compares volatile anaesthetic sedation against conventional intravenous sedation approaches in mechanically ventilated ICU patients to evaluate effects on respiratory function and clinical outcomes.
  • Patient eligibility overview: The study enrolls critically ill patients requiring mechanical ventilation and sedation in the ICU; specific inclusion/exclusion criteria would determine suitability based on underlying condition severity and contraindications.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This study will investigate how different types of routine sedation may affect patient's breathing whilst on a ventilator in the Intensive Care Unit (ICU). There are different approaches to sedation which may have advantages and disadvantages. During the study patients will receive both intravenous and inhaled volatile sedation (similar to anaesthetic 'gases' used for general anaesthesia) and the drive to breath, breathing efforts and function of the lung will be assessed.

Eligibility Snapshot
  • : * Adult patients admitted to the Intensive Care Unit (ICU) * ARDS * Invasive mechanical ventilation (IMV) * Spontaneous breathing in pressures support mode (PSV) for less than or equal to 48 hours * Sedated with intravenous sedation (ie. propofol and / or midazolam and fentanyl or alternate short acting opioid) * Anticipated to remain on IMV and PSV and with a stable sedation score for a further 24 hours without planned sedation interruption / spontaneous breathing trial or other significant change in the level of ventilator support * Not receiving / anticipated to receive paralysis * In supine position

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
UK Achondroplasia Network’s consensus guideline for multidisciplinary care of children and young people with achondroplasia: NICE review
Respiratory / COPD / Asthma · 19 May 2026
Establish multidisciplinary team review at diagnosis and at key developmental stages (infancy, pre-school, school age, adolescence) to monitor for complications including spinal…
View guideline →
Clinical Brief
Over one million children referred for mental healthcare – with anxiety the main reason
Respiratory / COPD / Asthma · BBC Health · 29 Jun 2026
Over one million children in England have been referred for mental healthcare, with anxiety as the leading presenting complaint, indicating a substantial…
View brief →
Clinical Brief
US mother begged for help before her children’s killings, mother-in-law testifies
Respiratory / COPD / Asthma · BBC Health · 18 Aug 2026
Postpartum psychosis represents a psychiatric emergency requiring urgent recognition and intervention, as illustrated by this case where a mother in acute distress…
View brief →
Guideline
Brensocatib for treating non-cystic fibrosis bronchiectasis in people 12 years and over (terminated evaluation)
Respiratory / COPD / Asthma · 25 Aug 2026
Evaluation terminated: Brensocatib for non-CF bronchiectasis is no longer under NICE appraisal—do not initiate new treatment pathways for this indication pending alternative…
View guideline →
Clinical Brief
Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision
Respiratory / COPD / Asthma · MHRA · 20 May 2026
Amiodarone carries serious risks of pulmonary, hepatic, and thyroid toxicity requiring baseline assessment and regular monitoring throughout treatment Patients on amiodarone require…
View brief →
Clinical Brief
What is postpartum psychosis and why is it central in the Lindsay Clancy trial?
Respiratory / COPD / Asthma · BBC Health · 19 Aug 2026
Postpartum psychosis is a rare but severe psychiatric emergency occurring in 1-2 per 1,000 deliveries, characterised by delusions, hallucinations, and disorganised thinking…
View brief →